Association of Bone Metastatic Burden With Survival Benefit From Prostate Radiotherapy in Patients With Newly Diagnosed Metastatic Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Ali A, Hoyle A, Haran ÁM, Brawley CD, Cook A, Amos C, Calvert J, Douis H, Mason MD, Dearnaley D, Attard G, Gillessen S, Parmar MKB, Parker CC, Sydes MR, James ND, Clarke NW.
N Engl J Med. 2018 Feb 15;378(7):645-657. doi: 10.1056/NEJMra1701695. Epub 2018 Feb 7.
PMID:29412780
Regulation of prostate cancer progression by the tumor microenvironment.
Shiao SL, Chu GC, Chung LW.
Cancer Lett. 2016 Sep 28;380(1):340-8. doi: 10.1016/j.canlet.2015.12.022. Epub 2016 Jan 28.
PMID:26828013
Application of Primary/Secondary Circulating Tumor Cells for the Prediction of Biochemical Recurrence in Nonmetastatic Prostate Cancer Patients following Radical Prostatectomy or Radiotherapy: A Meta-Analysis.
Cao L, Hao P, Lin D, Li Y, Hu T, Cai T, Cui S, Wu T.
Biomed Res Int. 2021 Sep 20;2021:4730970. doi: 10.1155/2021/4730970. eCollection 2021.
PMID:34595236
miRNA-877-5p inhibits malignant progression of prostate cancer by directly targeting SSFA2.